|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1 Pt 1
|
|
pubmed:dateCreated |
1996-3-4
|
|
pubmed:abstractText |
We studied the efficacy, safety, and acceptability of an estradiol-releasing (6.5 to 9.5 micrograms per 24 hours) silicone vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging during a treatment period of 1 year.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0002-9378
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
174
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
85-92
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8572039-Administration, Intravaginal,
pubmed-meshheading:8572039-Aging,
pubmed-meshheading:8572039-Atrophy,
pubmed-meshheading:8572039-Consumer Satisfaction,
pubmed-meshheading:8572039-Estradiol,
pubmed-meshheading:8572039-Female,
pubmed-meshheading:8572039-Female Urogenital Diseases,
pubmed-meshheading:8572039-Humans,
pubmed-meshheading:8572039-Mucous Membrane,
pubmed-meshheading:8572039-Pessaries,
pubmed-meshheading:8572039-Vagina
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, University Hospital, Malmö, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
